Key Deal Facts
Backed by Peninsula Capital Management, Jumpstart Foundry & Right Side Capital
Built by chronic Lyme patients alongside Lyme, Long COVID & complex chronic illness experts
Live in 46 states | $10K Monthly Recurring Revenue (MRR) | 5 providers & growing (MDs, NPs, NDs)
93% of patients said they would highly recommend Ravel | 5-star Google rating
Working w/MIT dev on AI-enhanced patient/provider matching & treatment summaries for providers
Collaborative research project w/Putrino Lab at Mount Sinai
Numerous marketing partnerships in place w/nationwide orgs, state assns, influencers & ambassadors
Over 50M people in U.S. suffer from Lyme, Long COVID, ME/CFS, fibromyalgia & other chronic illness
Management Team / Advisory Board Bios
VC-Backed
Raised $250K or more from a venture firm, Kevin WilliamsCo-FounderChronic Lyme patient, software development firm founder & tech entrepreneur who’s completed hundreds of digital projects, with tens of thousands of collective users, Jaime IntileCo-FounderChronic Lyme patient with decades of experience in
marketing & leadership development and a proven track record for building highly successful teams, William RawlsChief Medical Officer (CMO)Bill Rawls, MD, is a physician of 30 years and a leading Lyme thought leader. When a health crisis in his late forties abruptly changed his quality of life, he came face-to-face with the distinct limitations of the conventional medical system., Monica E. Embers, PhDAdvisory TeamDr. Embers is currently an Associate Professor in the Division of Immunology, Head of the Education and Training Program, and the Director of Vector-borne Disease Research at the Tulane National Primate Research Center., Dr. Darin Ingels, NDAdvisory TeamNaturopathic Doctor, author, international speaker & leading authority on Lyme, who overcame his own 3-year battle with the disease
